Evidence map›Paper›PMID 20430023›Full record

ArticleExperimental cell research2010

TRAM1 is involved in disposal of ER membrane degradation substrates.

Caroline L Ng, Kristina Oresic, Domenico Tortorella

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. TRAM1 Promotes Microglia M1 Polarization.Journal of molecular neuroscience : MN · 2016
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Caroline L NgOne Gustave L. Levy Place, Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029, USA. caroline.ng@mssm.edu
Kristina Oresic
Domenico Tortorella
Icahn School of Medicine at Mount Sinai · US

Funding

Down-regulation of MHC class l molecules by HCMV US2R01AI060905 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI TORTORELLA, DOMENICO · 2005 to 2009
$1.8M
NIAID NIH HHS AI060905NIAID NIH HHS R01 AI060905
6 · The paper itself

Abstract

ER quality control consists of monitoring protein folding and targeting misfolded proteins for proteasomal degradation. ER stress results in an unfolded protein response (UPR) that selectively upregulates proteins involved in protein degradation, ER expansion, and protein folding. Given the efficiency in which misfolded proteins are degraded, there likely exist cellular factors that enhance the export of proteins across the ER membrane. We have reported that translocating chain-associated membrane protein 1 (TRAM1), an ER-resident membrane protein, participates in HCMV US2- and US11-mediated dislocation of MHC class I heavy chains (Oresic, K., Ng, C.L., and Tortorella, D. 2009). Consistent with the hypothesis that TRAM1 is involved in the disposal of misfolded ER proteins, cells lacking TRAM1 experienced a heightened UPR upon acute ER stress, as evidenced by increased activation of unfolded protein response elements (UPRE) and elevated levels of NF-kappaB activity. We have also extended the involvement of TRAM1 in the selective degradation of misfolded ER membrane proteins Cln6(M241T) and US2, but not the soluble degradation substrate alpha(1)-antitrypsin null(HK). These degradation model systems support the paradigm that TRAM1 is a selective factor that can enhance the dislocation of ER membrane proteins.

Indexed as

alpha 1-AntitrypsinBlotting, WesternCells, CulturedEndoplasmic ReticulumHumansIntracellular MembranesKidneyLuciferasesMembrane GlycoproteinsMembrane ProteinsMembrane Transport ProteinsNF-kappa BProtein TransportReverse Transcriptase Polymerase Chain ReactionRNA, MessengerUnfolded Protein Responsealpha 1-AntitrypsinCLN6 protein, humanLuciferasesMembrane GlycoproteinsMembrane ProteinsMembrane Transport ProteinsNF-kappa BRNA, MessengerTRAM1 protein, human

Identifiers

PMID20430023
PMCPMC2900547
OpenAlexW2021406938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.